Press release
CAR-T Cell Therapy Market Research, Recent Trends And Growth Forecast 2026: Bluebird Bio (US), Celgene Corporation (US), Gilead Sciences, Inc. (US), Cellectis (France), Servier Laboratories (France), Pfizer Inc. (US), Mereck KGaA (Germany), Amgen Inc. (US
CAR-T Cell Therapy Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for the CAR-T Cell Therapy market between 2020 and 2026. In terms of value, the CAR-T Cell Therapy industry is expected to register a steady CAGR during the forecast period.According to the analysis by Polaris Market Research, the potential of the market is ~ $9 billion by 2026, with major focus on Diffuse Large B-Cell Lymphoma (DLBCL) indication in 2020-21. However, it is expected that the market would also start focusing on Multiple Myeloma (MM) indication and the market for the same is expected to grow at a compounded annual growth rate of more than 80% from 2020 to 2026.
Request a Sample Copy@ https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-sample
The key players covered in this study
o Pfizer Inc
o Bluebird Bio
o Celgene Corporation
o Gilead Sciences
o Cellectis
o Servier Laboratories
o Mereck KGaA
o Amgen Inc
o Intellia Therapeutics
o Novartis International AG
o Caribou Biosciences, Inc
o Celyad
o Bellicum Pharmaceuticals
o Noile-Immune Biotech
o Nanjing Legend Biotechnology Co
o Johnson & Johnson
o Sangamo Therapeutics, Inc
Market segment by Type, the product can be split into
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
Market segment by Application, split into
o Healthcare
o Others
Get Offer on Report: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-discount-pricing
It is estimated that U.S. is one of the major markets for CAR-T Cell Therapy due to continuous R&D happening in this region also backed by ongoing regulatory approvals of the new therapies. Along with the new therapy developments, companies are also focusing on establishing centers for cancer awareness and how this novel therapy would help in cancer treatment. This would help the market to grow in this region. The European region is also expected to closely follow by U.S. wherein European Medicine Agencies (EMA) have approved Kymriah and Yescarta which is expected to push the market for further growth in this region. However, the market for Asia Pacific is at its early stages wherein Ministry of Health, Labor and Welfare (MHLW) of Japan is the first regulatory authority to approve Kymriah in APAC.
It can be seen that the business scenario of the market is dynamic and major companies are competing with each other to increase their market share in the major geographies of U.S. and Europe. For example, Novartis and Gilead came-up with 33 and 28 authorized centers respectively in U.S. Some of the major companies in this space such as Celgene are expected to file for FDA approvals for two more CAR-Ts lisocabtagene maraleucel in lymphoma and bb2121 (idecabtagene vicleucel) in myeloma.
Along with opening new centers and acquiring necessary government approvals, the companies are also focusing on partnerships, acquisitions and mergers. For instance, Celgene acquired Juno Therapeutics in November 2020 for approximately $9 billion in 2020 and further Bristol-Myers Squibb completed its acquisition of Celgene in November 2019.
Else place an Inquire before Purchase "Global CAR-T Cell Therapy Market Size, Status and Forecast 2026: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/inquire-before-buying
About Us
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world
Get n Touch:
Mr. Likhil
Corporate Sales
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CAR-T Cell Therapy Market Research, Recent Trends And Growth Forecast 2026: Bluebird Bio (US), Celgene Corporation (US), Gilead Sciences, Inc. (US), Cellectis (France), Servier Laboratories (France), Pfizer Inc. (US), Mereck KGaA (Germany), Amgen Inc. (US here
News-ID: 1995265 • Views: …
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Therap
Natural Killer Cell Therapies Clinical Trials, Companies, Therapeutic Assessment …
DelveInsight's, "Natural Killer Cell Therapies - Pipeline Insight, 2025," report provides comprehensive insights about 100+ companies and 140+ pipeline drugs in Natural Killer Cell Therapies pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over 100 key…
Hemophilia Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatm …
DelveInsight's, "Hemophilia- Pipeline Insight, 2025," report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Hemophilia Pipeline constitutes 80+ key companies continuously working towards developing 80+ Hemophilia treatment…
Autosomal Dominant Polycystic Kidney Disease Market Forecasted to Surge in Comin …
The Key Autosomal Dominant Polycystic Kidney Disease Companies in the market include - Otsuka America Pharmaceuticals, Vertex Pharmaceuticals, Pfizer, Otsuka Pharma, Palladio Biosciences, Novartis Pharma, XORTX Therapeutic, Reata Pharmaceuticals, Kyowa Kirin, Sanofi, Galapagos NV, Janssen Pharmaceuticals, Regulus Therapeutics, and others.
DelveInsight's "Autosomal Dominant Polycystic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Autosomal Dominant Polycystic Kidney Disease, historical and forecasted epidemiology as well as…
Empowering Growth: Bedaquiline Fumarate Medications Market 2024 and Industry Seg …
The latest research study released by Worldwide Market Reports on "Bedaquiline Fumarate Medications Market 2024 Forecast to 2031" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Bedaquiline Fumarate Medications industry, as…
Retinitis Pigmentosa Treatment Market Size 2024 | Johnson & Johnson Innovative M …
DelveInsight's "Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of historical and forecasted epidemiology as well as the Retinitis Pigmentosa market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Key Takeaways from the Retinitis Pigmentosa Market Report
• In the US, the total number of prevalent cases of retinitis pigmentosa were ~113,000 in 2023.
• Nonsyndromic retinitis…
ANCA-associated Vasculitis Market is Predicted to Exhibit Remarkable Growth Duri …
DelveInsight's "ANCA-associated Vasculitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the ANCA-associated Vasculitis, historical and forecasted epidemiology as well as the ANCA-associated Vasculitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the ANCA-associated Vasculitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; ANCA-associated Vasculitis Market Forecast
https://www.delveinsight.com/sample-request/anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…